In today’s recent session, 0.43 million shares of the ABVC BioPharma Inc (NASDAQ:ABVC) have been traded, and its beta is 0.21. Most recently the company’s share price was $2.09, and it changed around $0.14 or 7.18% from the last close, which brings the market valuation of the company to $35.49M. ABVC at last check was trading at a discount to its 52-week high of $1.98, offering almost 5.26% off that amount. The share price’s 52-week low was $0.40, which indicates that the recent value has risen by an impressive 80.86% since then.

ABVC BioPharma Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended ABVC as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.

ABVC BioPharma Inc (NASDAQ:ABVC) trade information

Instantly ABVC has been showing a green trend so far today with a performance of 7.18% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 2.2500 on recent trading dayincreased the stock’s daily price by 7.11%. The company’s shares are currently up 254.24% year-to-date, but still up 25.90% over the last five days. On the other hand, ABVC BioPharma Inc (NASDAQ:ABVC) is 41.22% up in the 30-day period.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 27.39%.

ABVC Dividends

ABVC BioPharma Inc’s next quarterly earnings report is expected to be released in July.